Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
12/11/2025
Cifi Holdings Group: The contract sales of real estate in October amounted to 1.1 billion yuan.
Latest
4 m ago
Shenzhen Stock Exchange: The list of securities included in the Hong Kong Stock Connect has been adjusted, and Kangji Medical will be removed from the list, effective November 12th.
5 m ago
Every AI Express News, Haitong International released a research report on November 12th, giving Aibo Medical (688050.SH) a "neutral" rating with a target price of 70.65 yuan. The reasons for the rating mainly include: 1) the company's profit in the first three quarters is under pressure, mainly due to increased competition in the artificial intraocular lens and contact lens industries; 2) the decline in net profit attributable to the parent company is mainly due to the decline in revenue from artificial intraocular lenses and contact lenses, as well as the company's increased promotion of its own brand of contact lenses; 3) in terms of artificial intraocular lenses, affected by the adjustment of the national centralized procurement and the structure of medical insurance expenditures in some provinces and cities, the company's revenue and sales volume of artificial intraocular lenses have both decreased compared to the same period in 2024; 4) in terms of contact lenses, influenced by the consumption market environment, terminal prices have declined, and with the intensification of competition due to the expansion of domestic production capacity, both the factory prices and profit margins of contact lenses have decreased. (Daily Economic News)
5 m ago
Arrival Kai Pharmaceutical: Enters into exclusive licensing agreement with Qilu Pharmaceutical, to receive a maximum of 2.045 billion yuan in upfront and milestone payments.
7 m ago
Fuchun Corporation: Actively promoting the preparation work for the launch of the game "Ragnarok Online: The Birth of a New Generation" in the Middle East, Europe, and other regions.
7 m ago
CITIC Securities' 2026 social services sector investment strategy: Focus on changes in economic conditions, optimistic about leading companies realizing growth.
See all latest
